Laxatives And Troponin Levels: An Unexpected Connection

Laxatives are not listed as a cause of elevated troponin levels in any of the sources.

Troponin refers to three different proteins that help regulate the contractions of the heart and skeletal muscles. Troponin levels in the blood are typically very low, but injuries to the heart can cause them to increase significantly.

Troponin levels are usually so low that standard blood tests cannot detect them. Even small increases in troponin can indicate some damage to the heart. High troponin levels are a symptom, not a diagnosis, so treatment will focus on finding and addressing the underlying cause.

Troponin levels typically start to elevate within two to three hours of the onset of chest pain. The levels will continue to rise until a peak is reached, generally between 12 and 48 hours. The troponin level will then fall to normal over the next four to ten days.

• Pain or discomfort in one or both arms, your back, shoulders, neck, jaw, or above your belly button
• Trouble breathing when resting or doing light physical activity
• Feeling unusually tired for no reason, sometimes for days
• Dizziness and light-headedness
• Sweating a lot for no reason
• Rapid or irregular heartbeat (arrhythmia) | | What are the conditions that can cause high troponin levels? | - Sepsis
• Kidney failure or chronic kidney disease
• Chemotherapy-related damage to the heart
• Myocarditis (heart inflammation)
• Heart damage from using recreational drugs, such as cocaine
• A traumatic injury to the heart, such as from a sudden, hard blow to the chest
• Intense exercise over a long time, such as running a marathon
• A blood clot in your lungs (pulmonary embolism)
• A severe COVID-19 infection |

Troponin levels and the diagnosis of heart attacks

Troponin levels are a vital tool in the diagnosis of heart attacks. Troponin is a protein found in the cells of the heart muscle and, to a lesser extent, in other muscles. When the heart muscle is damaged, troponin is released into the bloodstream, and so a blood test can be used to detect it.

Troponin tests are usually carried out in hospital emergency rooms when a patient is suspected of having had a heart attack. The test is often done alongside an EKG (electrocardiogram) and a physical examination. A doctor will also take into account the patient's symptoms and medical history.

The troponin test is not used to diagnose a heart condition on its own. However, it is a key tool in assessing the extent of any heart damage, which can then guide treatment decisions. The more damage there is to the heart, the more troponin is released into the blood. Troponin levels usually increase sharply within three to 12 hours of a heart attack and peak about 24 hours after the event. They will remain high for several days.

There are two types of troponin that are more detectable after heart muscle damage: troponin I (cTnI) and troponin T (cTnT). Troponin I is unique to the heart muscle, while troponin T is found in other types of muscle but in very limited amounts. Troponin T from the heart also has a slightly different structure, which allows doctors to tell where it has come from.

Troponin tests have become much more sensitive in recent years. They can now detect much smaller amounts of troponin in the bloodstream than previous versions of the tests. This can help doctors diagnose a heart attack or rule it out more quickly.

Troponin levels and other causes of heart damage

Troponin is a protein that helps regulate the contractions of the heart and skeletal muscles. It is normally found inside the heart muscle cells, but when the heart sustains damage, troponin is released into the bloodstream. Troponin levels in the blood are typically very low, but injuries to the heart can cause them to increase significantly.

Troponin tests are primarily used to diagnose heart attacks, but they can also be used to diagnose and monitor unstable angina, check heart health after surgery, and identify people at risk of heart failure. The test measures the level of troponin in a blood sample, and higher-than-normal levels indicate damage to the heart muscle.

There are two types of troponin that are used to diagnose heart damage: troponin I (cTnI) and troponin T (cTnT). Troponin I is found only in the heart muscle, while troponin T is found in very small amounts in other muscles, in addition to the heart. The structure of troponin T in the heart differs slightly from that found elsewhere in the body, allowing doctors to determine the location of the damage.

Troponin levels usually increase sharply within three to 12 hours after a heart attack and peak about 24 hours after the event. They will remain high for several days, and in the case of troponin T, up to three weeks.

In addition to a heart attack, there are several other conditions that can cause elevated troponin levels, including:

• Chronic kidney disease
• Pulmonary embolism (a blood clot in the lungs)
• Congestive heart failure
• Heart valve diseases
• Irregular heart rhythms (arrhythmias)
• Intense or prolonged exercise
• Extreme emotional strain or stress
• Cardioversion (use of electric shock to restore a normal heart rhythm)
• Infection or inflammation of the heart muscle (myocarditis)
• Direct myocardial trauma, such as a blow to the chest

Troponin levels and chronic kidney disease

Troponin levels are usually so low that standard blood tests cannot detect them. However, injuries to the heart can cause them to increase significantly. Troponin is a protein complex of three subunits: troponin C, troponin I, and troponin T. Troponin C binds calcium and transports troponin I so muscles can contract, while troponin T binds troponin proteins to muscle fibres.

Troponin tests are mainly used to diagnose heart attacks. Heart attacks damage the heart by suddenly blocking the blood flow that brings oxygen to the heart muscle. Without oxygen, heart muscle cells die and release troponin. The more damage there is to the heart, the more troponin is released into the blood.

Troponin levels can be elevated in patients with chronic kidney disease (CKD), even in the absence of clinical myocardial ischemia. The prevalence of coronary artery disease in patients with CKD is high, and acute myocardial infarction contributes significantly to the steep mortality rate in this population. Diagnosing an acute coronary syndrome in these patients is often difficult but essential. Traditional diagnostic tools such as symptoms and electrocardiographic manifestations are not always helpful in patients with CKD, so physicians often rely on laboratory analysis of biomarkers such as cardiac troponin.

Several theories have been proposed for the mechanism of elevated troponin levels in CKD. One theory suggests that reduced clearance of troponin contributes to elevated levels in patients with CKD. However, this is improbable as troponins are very large molecules and unlikely to be cleared by the kidneys. Another theory suggests that there is a micro-loss of cardiac myocytes from the normal heart, which is more noticeable in patients with CKD due to reduced clearance of small troponin fragments.

There is a strong prognostic implication of elevated troponin levels in patients with CKD. Elevated troponin levels in otherwise stable patients with CKD are associated with a 2–5-fold increased risk of death, both in the short and long term. In addition, elevated troponin levels can be suggestive of acute myocardial necrosis. A distinct rise and fall in troponin levels over the baseline strongly support the diagnosis of acute myocardial necrosis.

Troponin levels and pulmonary embolism

Troponin is a protein found in the cells of the heart muscle. Troponin levels in the blood are typically very low, but when the heart muscle is damaged, troponin leaks into the bloodstream, causing an increase in troponin levels. Troponin tests are primarily used to diagnose heart attacks, but they can also be used to diagnose pulmonary embolism (PE).

Troponin and Heart Attacks

The heart releases troponin I and troponin T into the blood following an injury, such as a heart attack. High troponin levels usually indicate a person has recently had a heart attack. The medical term for this is myocardial infarction.

Troponin and Pulmonary Embolism

Troponin levels can also be used to diagnose pulmonary embolism, which is the occlusion of the pulmonary artery or its branches. PE can be caused by various substances, such as thrombus, fat, air, bone marrow, amniotic fluid, and septic material.

In acute PE, the mechanical load on the right ventricle increases due to increased pulmonary vascular resistance following pulmonary artery obstruction. This can lead to acute right ventricular dilatation, causing severe myocardial ischemia and increased troponin levels.

Troponin Levels and PE Diagnosis

Troponin testing is useful in the diagnosis of PE, as elevated troponin levels can indicate severe PE. In a study of 106 patients with suspected PE, 50.8% of those with PE had high troponin levels, compared to only 11.6% of those without PE. Troponin levels can be used in conjunction with evidence of right ventricular strain on echocardiography or computed tomography to identify patients at risk of becoming hemodynamically unstable.

Troponin Levels and Prognosis

Elevated troponin levels in PE patients have been associated with the severity and prognosis of the disease. Patients with massive PE are more likely to have high troponin levels than those with sub-massive or non-massive PE. Additionally, PE patients with high troponin levels are more likely to develop cardiogenic shock and have a higher risk of mortality.

In conclusion, troponin levels can be a useful tool in the diagnosis and prognosis of pulmonary embolism, particularly when used in conjunction with other diagnostic tests and clinical parameters.

Troponin levels and sepsis

Troponin levels are usually so low that standard blood tests cannot detect them. However, injuries to the heart can cause them to increase significantly. Troponin levels in the blood can be used to assess the extent of any heart damage and guide treatment decisions.

Troponin levels can be elevated due to both cardiac and noncardiac conditions. Sepsis is a noncardiac condition that can cause elevated troponin levels. It is a severe and potentially life-threatening reaction to an infection entering the bloodstream.

Sepsis is associated with increased mortality in intensive care patients. In the context of sepsis, troponin elevation is not a direct indicator of myocardial infarction or necrosis. Instead, it is likely related to leakage of troponin from the cardiac myocyte membrane, which is a reversible process in most surviving patients.

The mechanism of myocyte insult leading to elevated troponin levels in sepsis is not yet fully understood. Proposed pathogenic mechanisms include:

• Demand-supply mismatch due to tachycardia, hypoxaemia, hypotension, and decreased oxygen delivery, resulting in decreased coronary perfusion pressure
• Direct myocarditis caused by bacteraemia, leading to cytokine and endotoxin release, microvascular dysfunction, bacterial myocarditis, myocardial depression, and increased myocardial cell membrane permeability
• Formation of free radicals and superoxide radicals due to the activation of NADPH oxidases complexes, resulting in myocardial cell damage and apoptosis
• Elevated filling pressures and ventricular wall stress, leading to activation of intracellular signalling cascades, cardiac myocyte apoptosis, and reduced coronary perfusion pressure
• Left ventricular diastolic and right ventricular systolic dysfunction

The majority of critically ill patients with sepsis and elevated troponin levels do not have flow-limiting coronary artery disease. However, a small group of patients with elevated troponin levels may have significant coronary artery disease. Therefore, it is important to determine which patients require further cardiac investigation.

Factors that may favour inpatient coronary angiography include very high levels of troponin, new or dynamic ECG changes, episodes of chest pain during admission, and significant new regional wall motion abnormality. The timing of angiography is typically once the index infection has settled.

While elevated troponin levels in sepsis are not indicative of myocardial infarction, they are associated with increased mortality. This may be due to myocardial dysfunction or a more fulminant disease process. Further research is needed to determine the underlying mechanisms and guide the management of septic patients with elevated troponin levels.

Frequently asked questions